{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:46:19Z","timestamp":1789069579578,"version":"build-2803163510"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014175","name":"Shanghai Municipal Health and Family Planning Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014175","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Alzheimer\u2019s disease (AD) is the most common type of neurodegenerative disease. Tau pathology is one of the pathological features of AD, and its progression is closely related to the progress of AD. Immune system dysfunction is an important mediator of Tau pathological progression, but the specific molecular mechanism is still unclear. The purpose of this study is to determine the immune hub genes and peripheral immune cell infiltration associated with the Braak stages, and the molecular mechanisms between them.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, 60 samples with different Braak stages in the GSE106241 dataset were used to screen Braak stages-related immune hub genes by using the WGCNA package in R and cytoHubba plugin. The temporal lobe expression data in the Alzdata database were used to verify the results. The correlation between the expression level of immune core genes and the pathological features of AD was analyzed to evaluate the abundance of peripheral immune cell infiltration and screened Braak stages-related cells. Finally, we used correlation analysis of immune hub genes and immune cells and Gene Set Enrichment Analysis (GSEA) of them.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Seven genes (GRB2, HSP90AA1, HSPA4, IGF1, KRAS, PIK3R1, and PTPN11) were identified as immune core genes after the screening of the test datasets and validation of independent data. Among them, Kirsten rat sarcoma viral oncogene homolog (KRAS) and Phosphoinositide-3-Kinase Regulatory Subunit 1 (PIK3R1) were the most closely related to Tau and A\u03b2 pathology in AD. In addition, the ImmuneScore increased gradually with the increase of Braak stages. Five types of immune cells (plasma cells, T follicular helper cells, M2 macrophage, activated NK cells, and eosinophils) were correlated with Braak stages. KRAS and PIK3R1 were the immune core genes most related to the abnormal infiltration of peripheral immune cells. They participated in the regulation of the pathological process of AD through axon guidance, long-term potentiation, cytokine\u2013cytokine receptor interaction, RNA polymerase, etc.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The KRAS and PIK3R1 genes were identified as the immune hub genes most associated with Tau pathological progress in AD. The abnormal infiltration of peripheral immune cells mediated by these cells was involved in the Tau pathological process. This provides new insights for AD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnagi.2022.887168","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T07:18:42Z","timestamp":1652167122000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Identification of Immune Hub Genes Associated With Braak Stages in Alzheimer\u2019s Disease and Their Correlation of Immune Infiltration"],"prefix":"10.3389","volume":"14","author":[{"given":"Xiao-hang","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-di","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-dong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12026-014-8516-1","article-title":"ImmPort: disseminating data to the public for the future of immunology.","volume":"58","author":"Bhattacharya","year":"2014","journal-title":"Immunol. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s42255-020-0228-3","article-title":"Eosinophils regulate adipose tissue inflammation and sustain physical and immunological fitness in old age.","volume":"2","author":"Brigger","year":"2020","journal-title":"Nat. Metab."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease.","volume":"23","author":"Busche","year":"2020","journal-title":"Nat. Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.it.2020.07.005","article-title":"Immunological features of non-neuronal brain cells: implications for Alzheimer\u2019s disease immunotherapy.","volume":"41","author":"Castellani","year":"2020","journal-title":"Trends Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-021-00476-x","article-title":"Cellular and pathological heterogeneity of primary tauopathies.","volume":"16","author":"Chung","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"B6","doi-asserted-by":"publisher","first-page":"5504","DOI":"10.1038\/s41380-021-01083-4","article-title":"Targeting innate immunity to protect and cure Alzheimer\u2019s disease: opportunities and pitfalls.","volume":"26","author":"Cisbani","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/s12864-017-3798-z","article-title":"Genome-wide network-based pathway analysis of CSF t-tau\/A\u03b21-42 ratio in the ADNI cohort.","volume":"18","author":"Cong","year":"2017","journal-title":"BMC Genomics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13024-021-00424-9","article-title":"New approaches to symptomatic treatments for Alzheimer\u2019s disease.","volume":"16","author":"Cummings","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"B9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/imr.12896","article-title":"The role of innate immunity in Alzheimer\u2019s disease.","volume":"297","author":"Ennerfelt","year":"2020","journal-title":"Immunol. Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nrneurol.2013.223","article-title":"Alzheimer disease therapy\u2013moving from amyloid-\u03b2 to tau.","volume":"9","author":"Giacobini","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.coi.2021.12.001","article-title":"T follicular helper cells in IgE-mediated pathologies.","volume":"74","author":"Gowthaman","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41583-020-0263-9","article-title":"Immune cell regulation of glia during CNS injury and disease.","volume":"21","author":"Greenhalgh","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12974-018-1309-z","article-title":"The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer\u2019s disease.","volume":"15","author":"Hopp","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s11011-020-00552-z","article-title":"Phosphoinositide-3-kinase regulatory subunit 1 gene polymorphisms are associated with schizophrenia and bipolar disorder in the Han Chinese population.","volume":"35","author":"Huang","year":"2020","journal-title":"Metab. Brain Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/eci.12072","article-title":"Alzheimer\u2019s disease and granulocyte density diversity.","volume":"43","author":"J\u00e4remo","year":"2013","journal-title":"Eur. J. Clin. Invest."},{"key":"B16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.arr.2017.08.005","article-title":"The role of the immune system in Alzheimer disease: etiology and treatment.","volume":"40","author":"Jevtic","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00401-020-02196-w","article-title":"The physiological roles of tau and A\u03b2: implications for Alzheimer\u2019s disease pathology and therapeutics.","volume":"140","author":"Kent","year":"2020","journal-title":"Acta Neuropathol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1136\/jnnp.73.3.261","article-title":"Genetic variability in the insulin signalling pathway may contribute to the risk of late onset Alzheimer\u2019s disease.","volume":"73","author":"Liolitsa","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies.","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1093\/brain\/awaa088","article-title":"Microglial activation and tau burden predict cognitive decline in Alzheimer\u2019s disease.","volume":"143","author":"Malpetti","year":"2020","journal-title":"Brain"},{"key":"B21","doi-asserted-by":"publisher","first-page":"E1316","DOI":"10.1073\/pnas.1525466113","article-title":"The adaptive immune system restrains Alzheimer\u2019s disease pathogenesis by modulating microglial function.","volume":"113","author":"Marsh","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B22","doi-asserted-by":"publisher","first-page":"101210","DOI":"10.1016\/j.arr.2020.101210","article-title":"The impact of aging in dementia: it is time to refocus attention on the main risk factor of dementia.","volume":"65","author":"Mecocci","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000486200","article-title":"Extravascular CD3+ T cells in brains of Alzheimer disease patients correlate with tau but not with amyloid pathology: an immunohistochemical study.","volume":"18","author":"Merlini","year":"2018","journal-title":"Neurodegener. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3390\/cancers13061204","article-title":"Targeting KRAS in cancer: promising therapeutic strategies.","volume":"13","author":"Mustachio","year":"2021","journal-title":"Cancers (Basel)."},{"key":"B25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles.","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.jaci.2019.03.017","article-title":"PI3K pathway defects leading to immunodeficiency and immune dysregulation.","volume":"143","author":"Nunes-Santos","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","article-title":"Microglial activation and tau propagate jointly across Braak stages.","volume":"27","author":"Pascoal","year":"2021","journal-title":"Nat. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"676621","DOI":"10.3389\/fimmu.2021.676621","article-title":"Immune response in neurological pathology: emerging role of central and peripheral immune crosstalk.","volume":"12","author":"Passaro","year":"2021","journal-title":"Front. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"101317","DOI":"10.1016\/j.arr.2021.101317","article-title":"Inflammatory pathways in Alzheimer\u2019s disease mediated by gut microbiota.","volume":"68","author":"Qian","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.4103\/1673-5374.332127","article-title":"Amyloid-beta peptide and tau protein crosstalk in Alzheimer\u2019s disease.","volume":"17","author":"Roda","year":"2022","journal-title":"Neural Regen. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13024-021-00452-5","article-title":"Protective genes and pathways in Alzheimer\u2019s disease: moving towards precision interventions.","volume":"16","author":"Seto","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"B32","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nprot.2015.052","article-title":"NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data.","volume":"10","author":"Xia","year":"2015","journal-title":"Nat. Protoc."},{"key":"B33","doi-asserted-by":"publisher","first-page":"111651","DOI":"10.1016\/j.biopha.2021.111651","article-title":"Tetrahydrocurcumin ameliorates Alzheimer\u2019s pathological phenotypes by inhibition of microglial cell cycle arrest and apoptosis via Ras\/ERK signaling.","volume":"139","author":"Xiao","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jalz.2017.08.012","article-title":"A systematic integrated analysis of brain expression profiles reveals YAP1 and other prioritized hub genes as important upstream regulators in Alzheimer\u2019s disease.","volume":"14","author":"Xu","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3233\/jad-215349","article-title":"putative factors interfering cell cycle re-entry in Alzheimer\u2019s disease: an omics study with differential expression meta-analytics and co-expression profiling.","volume":"85","author":"Yuen","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1093\/brain\/awt210","article-title":"Inflammatory components in human Alzheimer\u2019s disease and after active amyloid-\u03b242 immunization.","volume":"136","author":"Zotova","year":"2013","journal-title":"Brain"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.887168\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T07:18:45Z","timestamp":1652167125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.887168\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":36,"alternative-id":["10.3389\/fnagi.2022.887168"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2022.887168","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,10]]},"article-number":"887168"}}